Fennec Pharmaceuticals Inc. Chief Financial Officer Robert Andrade filed a Form 4 on November 2, 2026, reporting the acquisition of 1,703 common shares released from restriction on October 31, 2026.

Key Highlights

  • Reporting person: Robert Andrade, Chief Financial Officer of Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
  • Transaction date: October 31, 2026
  • Shares acquired: 1,703 common shares, coded as an acquisition (A) at a price of $0
  • Source of shares: Released from restriction from shares awarded on May 16, 2024, and March 28, 2025, according to the filing
  • Beneficial ownership following transaction: 248,558 common shares held directly
  • No derivative securities were reported in Table II of the filing

CFO Andrade's Restricted Share Release at Fennec Pharmaceuticals

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Robert Andrade, Chief Financial Officer of Fennec Pharmaceuticals Inc. (NASDAQ:FENC), reported a single non-derivative transaction on October 31, 2026. The filing reflects the acquisition of 1,703 common shares at a price of $0, representing shares released from a prior restriction rather than an open-market purchase.

The filing's explanation of responses states that the shares represent "shares released from restriction from shares awarded 5/16/2024 and 3/28/2025." Following this transaction, Andrade directly holds 248,558 common shares of Fennec Pharmaceuticals, as reported in the filing. The transaction code recorded is "A" (acquisition), and ownership is listed as direct.

No derivative securities, including options, warrants, or convertible instruments, were reported in Table II of this filing. The Form 4 was filed by one reporting person and was signed by Robert Andrade on November 2, 2026.

What Was Disclosed

Fennec Pharmaceuticals CFO Robert Andrade disclosed the vesting and release of 1,703 restricted common shares on October 31, 2026, derived from awards granted in 2024 and 2025, bringing his total direct beneficial ownership to 248,558 shares.